Prediction of Short-Term Breast Cancer Risk Based on Deep Convolutional Neural Networks in Mammography

2019 ◽  
Vol 9 (8) ◽  
pp. 1663-1672
Author(s):  
Yane Li ◽  
Ming Fan ◽  
Shichen Liu ◽  
Bin Zheng ◽  
Lihua Li

This work investigated a novel framework of predicting short-term breast cancer risk by using a deep learning approach in mammography. A dataset of 675 negative screening cases were applied. 333 cases were cancer diagnosed at next screening, while 342 cases remained negative. In order to stratify these patients into high and low cancer risk group, we first used an automatically method to segment bilateral matched central regions from right and left mammography respectively. Then, three AlexNet, GoogLeNet and ResNet based deep learning models were established with ten-fold cross validation method for both difference image of bilateral matched central regions and two whole regions of bilateral breasts respectively. Using AlexNet-, GoogLeNet- and ResNet-based risk model, areas under ROC curves (AUC) are 0.56, 0.62 and 0.64 for central regions and 0.59, 0.57 and 0.65 for whole regions, respectively. When combining prediction scores of three deep learning models with a multi-agent fusion algorithm, AUCs are 0.67 and 0.67 for central regions and whole regions respectively. When fusing scores of central region-based risk model and whole region-based risk model, AUC significantly increases to 0.71 (p < 0.01). By dividing 675 cases into five subgroups based on sorting results of risk scores, the odds ratios had an significant increasing trend as the scores increased (p = 0 003). This study demonstrates feasibility of applying deep learning technology to assist investigating novel markers in mammography for helping assessment of short-term breast cancer risk and improving the efficiency of breast cancer screening in the future.

2020 ◽  
Vol 35 (6) ◽  
pp. 1253-1255
Author(s):  
Zeev Blumenfeld ◽  
Norbert Gleicher ◽  
Eli Y Adashi

Abstract Whereas longstanding dogma has purported that pregnancies protect women from breast cancer, a recent meta-analysis now mandates reconsideration since it reported an actual higher breast cancer risk for more than two decades after childbirth before the relative risk turns negative. Moreover, the risk of breast cancer appears higher for women having their first birth at an older age and with a family history and it is not reduced by breastfeeding. The process of obtaining informed consent for all fertility treatments, therefore, must make patients aware of the facts that every pregnancy, to a small degree, will increase the short-term breast cancer risk. This observation may be even more relevant in cases of surrogacy where women agree to conceive without deriving benefits of offspring from assuming the risk, thus creating a substantially different risk-benefit ratio. Consequently, it appears prudent for professional societies in the field to update recommendations regarding consent information for all fertility treatments but especially for treatments involving surrogacy.


2019 ◽  
Vol 47 (1) ◽  
pp. 110-118 ◽  
Author(s):  
Dooman Arefan ◽  
Aly A. Mohamed ◽  
Wendie A. Berg ◽  
Margarita L. Zuley ◽  
Jules H. Sumkin ◽  
...  

2021 ◽  
Vol 13 (578) ◽  
pp. eaba4373 ◽  
Author(s):  
Adam Yala ◽  
Peter G. Mikhael ◽  
Fredrik Strand ◽  
Gigin Lin ◽  
Kevin Smith ◽  
...  

Improved breast cancer risk models enable targeted screening strategies that achieve earlier detection and less screening harm than existing guidelines. To bring deep learning risk models to clinical practice, we need to further refine their accuracy, validate them across diverse populations, and demonstrate their potential to improve clinical workflows. We developed Mirai, a mammography-based deep learning model designed to predict risk at multiple timepoints, leverage potentially missing risk factor information, and produce predictions that are consistent across mammography machines. Mirai was trained on a large dataset from Massachusetts General Hospital (MGH) in the United States and tested on held-out test sets from MGH, Karolinska University Hospital in Sweden, and Chang Gung Memorial Hospital (CGMH) in Taiwan, obtaining C-indices of 0.76 (95% confidence interval, 0.74 to 0.80), 0.81 (0.79 to 0.82), and 0.79 (0.79 to 0.83), respectively. Mirai obtained significantly higher 5-year ROC AUCs than the Tyrer-Cuzick model (P < 0.001) and prior deep learning models Hybrid DL (P < 0.001) and Image-Only DL (P < 0.001), trained on the same dataset. Mirai more accurately identified high-risk patients than prior methods across all datasets. On the MGH test set, 41.5% (34.4 to 48.5) of patients who would develop cancer within 5 years were identified as high risk, compared with 36.1% (29.1 to 42.9) by Hybrid DL (P = 0.02) and 22.9% (15.9 to 29.6) by the Tyrer-Cuzick model (P < 0.001).


2015 ◽  
Vol 150 (3) ◽  
pp. 643-653 ◽  
Author(s):  
Bernard Rosner ◽  
A. Heather Eliassen ◽  
Adetunji T. Toriola ◽  
Susan E. Hankinson ◽  
Walter C. Willett ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document